AMN Healthcare's Q4 revenue beats estimates on nurses & allied staffing strength

Reuters02-20
<a href="https://laohu8.com/S/AMN">AMN Healthcare</a>'s Q4 revenue beats estimates on nurses & allied staffing strength

Overview

  • Healthcare staffing firm's Q4 revenue rose 2%, beating analyst expectations

  • Adjusted EPS for Q4 missed analyst expectations

  • Company reduced debt by $75 mln in Q4, totaling $285 mln for the year

Outlook

  • AMN Healthcare projects Q1 2026 revenue between $1.225 bln and $1.240 bln

Result Drivers

  • NURSE AND ALLIED STAFFING - Revenue growth driven by better-than-expected results in nurse and allied staffing, including a large labor disruption event

  • TRAVEL NURSE VOLUME - Travel nurse volume grew 5% sequentially due to increased winter orders and strong execution

  • ALLIED BUSINESS GROWTH - Allied business experienced sequential growth driven by strong performance in the schools business

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Beat

$748.20 mln

$723.70 mln (9 Analysts)

Q4 Adjusted EPS

Miss

$0.22

$0.28 (8 Analysts)

Q4 EPS

-$0.20

Q4 Net Income

-$7.70 mln

Q4 Gross Margin

26.10%

Q4 Operating margin

1.10%

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 5 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy."

  • Wall Street's median 12-month price target for AMN Healthcare Services Inc is $21.00, about 23% above its February 18 closing price of $17.08

  • The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 19 three months ago

Press Release: ID:nGNX80cZk0

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment